How many studies have been conducted on Apolipoprotein B 100?

BiohacksAI has indexed 300 PubMed studies on Apolipoprotein B 100, including 7 randomized controlled trials (RCTs). 31% of studies involve human subjects.

What are the main research areas for Apolipoprotein B 100?

The primary research domains for Apolipoprotein B 100 are ❤️ Cardiovascular, 🔥 Metabolic, 🫁 Liver & Detox. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Apolipoprotein B 100

A 513-kDa protein synthesized in the LIVER. It serves as the major structural protein of low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). It is the ligand for the LDL receptor (RECEPTORS, LDL) that promotes cellular binding and internalization of LDL particles.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 50.1

Research Domains

Apolipoprotein B 100 has been studied across 19 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫁 Liver & Detox, 😴 Sleep, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 40% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apolipoprotein B 100 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.